Geo News
Community curated by people like you
Latest
AI
Crypto
Health
World Affairs
US Politics
Retatrutide Achieves Up to 30.3% Average Weight Loss in Phase 3 TRIUMPH-1 Trial | AJMC
Ajmc
View source article
Retatrutide Achieves Up to 30.3% Average Weight Loss in Phase 3 TRIUMPH-1 Trial | AJMC — Ajmc
Featured Stories
OpenAI pauses development of Astra AI model over critical cybersecurity capability concerns
Aug 7, 2026
·
2 sources
